North Shore Long Island Jewish Medical Center — New York, New York

North Shore Long Island Jewish Medical Center is a clinical research site located in New York, New York, United States 10024.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

North Shore Long Island Jewish Medical Center has participated in 2 clinical trials.

Therapeutic areas: Acute Myelogenous Leukemia, Lysosomal Acid Lipase Deficiency, Wolman Disease.

Sponsors: Calithera Biosciences, Inc, Alexion Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North Shore Long Island Jewish Medical Center?

North Shore Long Island Jewish Medical Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North Shore Long Island Jewish Medical Center conducted?

North Shore Long Island Jewish Medical Center has 2 clinical trials on record. Their work covers Acute Myelogenous Leukemia, Lysosomal Acid Lipase Deficiency, Wolman Disease.

Is North Shore Long Island Jewish Medical Center accredited by Crixeo Health?

North Shore Long Island Jewish Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about North Shore Long Island Jewish Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.